Some important points
- At this time, no product that has tested positive or alerted for Cesium-137 (Cs-137) has entered the U.S. marketplace.
- FDA detected Cs-137 in a single shipment of imported frozen shrimp from PT. Bahari Makmur Sejati that did not enter U.S. commerce. The level of Cs-137 detected in the detained shipment was approximately 68 Bq/kg, which is below FDA’s Derived Intervention Level for Cs-137 of 1200 Bq/kg. At this level, the product would not pose an acute hazard to consumers.
- The primary health effect of concern following longer term, repeated low dose exposure (e.g., through consumption of contaminated food or water over time) is an elevated risk of cancer, resulting from damage to DNA within living cells of the body.
- FDA is working with distributors and retailers that received product from PT. Bahari Makmur Sejati after the date of first detection of Cs-137 by Customs & Border Protection (CBP), but from shipments that did not alert for Cs-137, to recommend that firms conduct a recall.
- FDA has also added PT. Bahari Makmur Sejati to a new import alert for chemical contamination to stop products from this firm from coming into the U.S. until the firm has resolved the conditions that gave rise to the appearance of the violation.
https://www.fda.gov/food/alerts-advisories-safety-information/fda-advises-public-not-eat-sell-or-serve-certain-imported-frozen-shrimp-indonesian-firm?utm_medium=email&utm_source=govdelivery
FDA Advises Public Not to Eat, Sell, or Serve Certain Imported Frozen Shrimp from an Indonesian Firm
Frozen shrimp imported from PT. Bahari Makmur Sejati is in violation of the Federal FD&C Act. Additional recalls have been added. FDA’s investigation is ongoing